Latest Riociguat Stories
WHIPPANY, N.J., May 15, 2015 /PRNewswire/ -- Bayer HealthCare will present data investigating pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in
Pulmonary arterial hypertension – a deadly, incurable lung condition – is one of only sixteen disease states FDA will focus on during the first three years of the Patient Focused Drug Development
-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides
Only a handful of the 7,000 rare diseases in the US have more than one treatment, and most have none.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.